Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis

Wang, R., & Maksymowych, W. P. (2021). Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.715510
Authors:
Runsheng Wang
Walter P Maksymowych
Affiliated Authors:
Runsheng Wang
Columbia Affiliation:
Subjects:
Anti-Inflammatory Agents (MeSH)
Axial Spondyloarthritis (MeSH)
Inflammation Mediators (MeSH)
Interleukin-17 (MeSH)
Interleukin-23 (MeSH)
Signal Transduction (MeSH)
Author Keywords:
il-23/il-17 axis
axial spondylarthritis
disease progression
inflammation
treatment
elink
Publication Type:
Article
Unique ID:
10.3389/fimmu.2021.715510
PMID:
34539646
DOI:
10.3389/fimmu.2021.715510
Journal:
Frontiers in Immunology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: